Format

Send to

Choose Destination
Clin Rheumatol. 2011 Feb;30(2):157-63. doi: 10.1007/s10067-010-1566-4. Epub 2010 Sep 15.

Evaluation of current therapeutic strategies in Behçet's disease.

Author information

1
First Department of Internal Medicine, University of Athens, Laikon Hospital, 69 Vosporou Str, Athens, 10444, Greece. aleiliana@yahoo.gr

Abstract

Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.

PMID:
20842513
DOI:
10.1007/s10067-010-1566-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center